• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Sweden

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand
Manufacturing

Nanologica acquires Ardena's Syntagon API facility in stock deal

Nanologica acquired CDMO Ardena’s Syntagon manufacturing facility in a stock deal valued at 8.6 million Swedish kroner ($961,000).
Joseph Keenan Feb 4, 2026 8:45am
ribbon cutting cutting ribbon opening debut

Recipharm builds out beta-lactam drug plant, secures new partner

Jan 26, 2026 9:50am
Doctor holding diagram of kidneys

Hansa eyes FDA filing after ph. 3 win for kidney transplant med

Sep 25, 2025 12:37pm
FDA

Swedish contract manufacturer hit with FDA warning letter

Jun 9, 2025 9:09am
Image of a neon sign with the word no lit up next to an unlit yes

FDA stymies Camurus' drug over 3rd-party manufacturing issues

Oct 22, 2024 9:53am
AZ

AstraZeneca plans $135M expansion of Swedish manufacturing site

Aug 27, 2024 10:02am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings